07:00 , Jun 7, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer BMX non-receptor tyrosine kinase (BMX; ETK) Mouse studies suggest inhibiting BMX could help treat cancer. In mouse models of melanoma,...
07:00 , Apr 21, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer BMX non-receptor tyrosine kinase (BMX; ETK) In vitro and mouse studies suggest that decreasing glioblastoma stem cell growth by inhibiting BMX could help...
07:00 , Apr 3, 2000 |  BioCentury  |  Finance

Pass the ladle

Pass the ladle...
07:00 , Oct 25, 1999 |  BC Week In Review  |  Clinical News

Synvisc modified natural hyaluronan regulatory update

BMX said the U.K. National Health Service will reimburse Synvisc as a prescription to treat osteoarthritis of the knee, allowing general practitioners and primary care physicians to prescribe Synvisc without referrals to a specialist. Biomatrix...